CLRB News and Press, Cellectar Biosciences Inc. From 02/20/20

Tivity Health (NASDAQ: TVTY )  -39%  on Q4 earnings . More news on: Tivity Health, Inc., Six Flags Entertainment Corporation, BioXcel Therapeutics, Inc., Stocks on the move, Read more ...

Gainers: Myomo (NYSEMKT: MYO ) +48% . More news on: Myomo, Inc., Enphase Energy, Inc., Altisource Asset Management Corporation, Stocks on the move, , Read more ...

Thinly traded nano cap Cellectar Biosciences (NASDAQ: CLRB ) slumps  23%  premarket on increased volume in reaction to results from a Phase 2 clinical trial, CLOVER-1 , evaluating lead candidater CLR 131 in patients with relapsed/refractory B-cell lymphomas. More news on: Cell...

42.8% ORR in multiple myeloma at the 75mCi total body dose 42.0% ORR and 11% CRR in all non-Hodgkin’s lymphoma (NHL) patients 100% ORR seen in Lymphoplasmacytic Lymphoma/Waldenstrom’s Macroglobulinemia (LPL/WM) patients 76.7% of the multiple myeloma ...

Are These The Best Stocks To Trade Before The End Of February 2020? It goes without saying that investing in penny stocks comes with a certain level of risk. But at the same time, these cheap stocks can often generate substantial returns in a short period of time. Over the years, plenty of...

The following slide deck was published by Cellectar Biosciences, Inc. in conjunction with this Read more ...

FLORHAM PARK, N.J., Jan. 09, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced that it will host a Clinical Da...

Humana ( HUM ) had a pretty decent 2019 as its stock rallied over 30 percent, delivering solid returns to investors. I don't generally cover non-pharma stocks, but this rally, coupled with some interesting news lately, has made HUM an interesting stock to watch. While the company made stride...

FLORHAM PARK, N.J., Jan. 07, 2020 (GLOBE NEWSWIRE) -- Cellectar Biosciences, Inc. (NASDAQ: CLRB), a clinical-stage biopharmaceutical company focused on the discovery, development and commercialization of drugs for the treatment of cancer, today announced it has appointed Dr. Igor Grachev as...

aTyr Pharma (NASDAQ: LIFE ) +63%  on Kyorin Pharma deal . More news on: aTyr Pharma, Inc., Town Sports International Holdings, Inc., Pulmatrix, Inc., Stocks on the move, Read more ...